Rheumatoid Arthritis and Sleep Disturbances: A Narrative Review of Bidirectional Mechanisms.
文献摘要
Rheumatoid arthritis (RA) is a systemic autoimmune disease in which sleep disturbances are common and closely linked to pain, fatigue, mood symptoms, physical dysfunction, and disease activity. This narrative review synthesizes clinical and mechanistic evidence for a bidirectional relationship between RA and impaired sleep while distinguishing diagnosed sleep disorders from transdiagnostic sleep symptoms. RA-related inflammation, pain, stiffness, and psychological comorbidity may impair sleep through peripheral-to-central inflammatory signaling, altered monoamine metabolism, circadian disruption, hypothalamic-pituitary-adrenal axis dysfunction, autonomic hyperarousal, and central sensitization. Conversely, insufficient or fragmented sleep may disrupt immune and circadian homeostasis, amplify pro-inflammatory signaling and pain sensitivity, and thereby worsen RA symptoms and possibly disease activity. However, much of the available evidence is cross-sectional, based on patient-reported sleep, or derived from small treatment studies, so direct causality and the independent contribution of individual pathways remain uncertain. Evidence from cytokine-blocking and sleep-directed interventions suggests potential benefit, but improvements may be mediated through changes in pain, fatigue, mood, and inflammatory activity. Age, sex, adiposity, medications, depression, anxiety, and sleep-disorder phenotype further modify these associations. Clinically, RA care should distinguish insomnia, obstructive sleep apnea, restless legs syndrome, circadian problems, and non-diagnostic sleep symptoms, then combine optimized RA and pain management with disorder-specific sleep treatment. Longitudinal multimodal cohorts and adequately powered trials using both patient-reported and objective sleep outcomes are priorities.